Programme

  1. Moderator: Dave Dillon, Senior Regulatory and Compliance Analyst, Chemical Watch, UK

  2. Welcome and introduction

  3. Session 1: Overviews

  4. European Commission overview

  5. Echa updates and developments

  6. Member state overview

  7. Industry feedback on the implementation of the BPR

  8. Q&A and panel discussion

  9. Break

  10. Session 2: Biocides enforcement

  11. Updates from the BPR subgroup of the Forum (BPRS) and BEF2

  12. Biocides enforcement in the Netherlands

    • Legislative framework  
    • Division of responsibilities                                                       
    • Enforcement organisation(s)  
    • Enforcement tools 
    • Enforcement reality in the Netherlands 
      • some figures and examples
    • Developments   
    • Wishful thinking from an enforcement point of view   
  13. Interaction with the UK authorities, including authorisation and enforcement aspects

    • Routes to market 
    • Key processes 
    • Case examples 
    • Challenges 
    • How regulatory authorities approach enforcement in the UK 
    • What to do if you are selected for inspection/investigation 
    • Hot topics 
  14. BPR enforcement and Italian national legislation

    • Domestic BPR enforcement: Italian decree 179/2021 – short description and comment
    • Use of criminal law by the domestic implementing regime
    • Existing domestic disinfectants legislation: a permanent parallel regime to certain authorised biocidal products
    • Final evaluations 
  15. Q&A and panel discussion

  16. Lunch and Chemical Watch demo 13.40-14.10

  17. Session 3: Regulatory processes

  18. Biocidal product family (BPF) authorisation in Germany: between the lines, essentials and pitfalls

    • Purpose of the BPF definition  
    • Overall authorisation process for BPFs in Germany 
    • Differences between biocidal product (BP) and BPF assessment highlighting the reasons behind certain approaches 

     

  19. Biocidal product families with quats: opportunities and challenges

    • Quats are likely to be big families because many products on the market are similar and have similar uses 
    • Possible challenges for these families: 
      • Identification of a backbone composition 
      • Complicated grouping strategy 
      • Presence of co-formulants with a biocidal function 
      • Similarity 
      • Definition of a worst-case scenario for efficacy 
  20. Current and future status of regulations for antifouling coatings globally

    • How are antifouling coatings regulated? 
    • Balance with the goals and regulations for effective biofouling control 
    • Global, regional and country regulations 
    • Recent environmental concerns 
    • Trends and the future of antifouling and biofouling regulations  

    Authors Neal Blossom (presenter) and Dr Colin Anderson 

  21. Q&A and panel discussion

  22. Break

  23. Session 4: Efficacy updates

  24. PT 19 efficacy guidance update: highlights of significant changes and applicability

    • Why a separate chapter for PT 19 efficacy assessment? 
    • What is new for PT 19 efficacy assessment? 
    • What does the future hold for PT 19 efficacy assessment? 
  25. Emerging CEN methods, updates to Echa EFF guidance and and Ecolab experience of efficacy portion of BPF

    • Overview of new methods under recent development within CEN  
    • Overview of upcoming guidance from Echa BPC EFF WG 
    • Brief recap of BPF efficacy approach and recent experiences from industry perspective 
  26. Emerging pathogens: the latest efficacy testing developments, requirements and technologies under FIFRA

    • Quantitative disinfection method (QM) 
    • Quantitative towelette method (QTM) 
    • Electrostatic sprayer (ESS) guidance 
    • Soft surface disinfection  
    • Residual hard surface methods 
    • Brief updates – viral, C. auris, air treatment 
  27. Q&A and panel discussion

  28. End of day 1